• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白质-能量消耗与慢性肾脏病患者的死亡率。

Protein-energy wasting and mortality in chronic kidney disease.

机构信息

Division of Nephrology, Dialysis and Transplantation, Department of Internal Medicine, Azienda Ospedale Università San Martino, Genoa University, Viale Benedetto XV 6, Genoa, Italy.

出版信息

Int J Environ Res Public Health. 2011 May;8(5):1631-54. doi: 10.3390/ijerph8051631. Epub 2011 May 19.

DOI:10.3390/ijerph8051631
PMID:21655142
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3108132/
Abstract

Protein-energy wasting (PEW) is common in patients with chronic kidney disease (CKD) and is associated with an increased death risk from cardiovascular diseases. However, while even minor renal dysfunction is an independent predictor of adverse cardiovascular prognosis, PEW becomes clinically manifest at an advanced stage, early before or during the dialytic stage. Mechanisms causing loss of muscle protein and fat are complex and not always associated with anorexia, but are linked to several abnormalities that stimulate protein degradation and/or decrease protein synthesis. In addition, data from experimental CKD indicate that uremia specifically blunts the regenerative potential in skeletal muscle, by acting on muscle stem cells. In this discussion recent findings regarding the mechanisms responsible for malnutrition and the increase in cardiovascular risk in CKD patients are discussed. During the course of CKD, the loss of kidney excretory and metabolic functions proceed together with the activation of pathways of endothelial damage, inflammation, acidosis, alterations in insulin signaling and anorexia which are likely to orchestrate net protein catabolism and the PEW syndrome.

摘要

蛋白质能量消耗(PEW)在慢性肾脏病(CKD)患者中很常见,并且与心血管疾病死亡风险增加有关。然而,即使是轻微的肾功能障碍也是不良心血管预后的独立预测因素,但 PEW 在晚期才表现出临床症状,甚至在透析阶段之前或早期就出现了。导致肌肉蛋白和脂肪损失的机制很复杂,并不总是与厌食症有关,但与刺激蛋白质降解和/或减少蛋白质合成的几种异常有关。此外,来自 CKD 实验的数据表明,尿毒症通过作用于肌肉干细胞,特异性地削弱了骨骼肌的再生潜能。在本次讨论中,我们探讨了导致 CKD 患者营养不良和心血管风险增加的机制的最新发现。在 CKD 过程中,肾脏排泄和代谢功能的丧失与内皮损伤、炎症、酸中毒、胰岛素信号改变和厌食症途径的激活同时发生,这些途径可能协调净蛋白质分解和 PEW 综合征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b884/3108132/01126164c983/ijerph-08-01631f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b884/3108132/db8d76afa6d2/ijerph-08-01631f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b884/3108132/01126164c983/ijerph-08-01631f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b884/3108132/db8d76afa6d2/ijerph-08-01631f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b884/3108132/01126164c983/ijerph-08-01631f2.jpg

相似文献

1
Protein-energy wasting and mortality in chronic kidney disease.蛋白质-能量消耗与慢性肾脏病患者的死亡率。
Int J Environ Res Public Health. 2011 May;8(5):1631-54. doi: 10.3390/ijerph8051631. Epub 2011 May 19.
2
Latest consensus and update on protein-energy wasting in chronic kidney disease.慢性肾脏病蛋白质能量消耗的最新共识与进展
Curr Opin Clin Nutr Metab Care. 2015 May;18(3):254-62. doi: 10.1097/MCO.0000000000000171.
3
Effect of kidney failure and hemodialysis on protein and amino acid metabolism.肾衰竭和血液透析对蛋白质和氨基酸代谢的影响。
Curr Opin Clin Nutr Metab Care. 2012 Jan;15(1):78-84. doi: 10.1097/MCO.0b013e32834d9df6.
4
Management of protein-energy wasting in non-dialysis-dependent chronic kidney disease: reconciling low protein intake with nutritional therapy.非透析依赖性慢性肾脏病中蛋白质-能量消耗的管理:在低蛋白摄入与营养治疗之间寻求平衡。
Am J Clin Nutr. 2013 Jun;97(6):1163-77. doi: 10.3945/ajcn.112.036418. Epub 2013 May 1.
5
Protein-energy wasting syndrome in advanced chronic kidney disease: prevalence and specific clinical characteristics.晚期慢性肾脏病中的蛋白质能量消耗综合征:患病率及特定临床特征
Nefrologia (Engl Ed). 2018 Mar-Apr;38(2):141-151. doi: 10.1016/j.nefro.2017.06.004. Epub 2017 Jul 26.
6
Handgrip strength is an independent predictor of renal outcomes in patients with chronic kidney diseases.握力是慢性肾脏病患者肾脏结局的独立预测因子。
Nephrol Dial Transplant. 2011 Nov;26(11):3588-95. doi: 10.1093/ndt/gfr013. Epub 2011 Mar 28.
7
Serum hepatocyte growth factor is associated with truncal fat mass and increased mortality in chronic kidney disease stage 5 patients with protein-energy wasting.血清肝细胞生长因子与5期慢性肾脏病合并蛋白质能量消耗患者的躯干脂肪量及死亡率增加相关。
Nephrol Dial Transplant. 2015 Feb;30(2):274-82. doi: 10.1093/ndt/gft265. Epub 2013 Aug 24.
8
Etiology of the protein-energy wasting syndrome in chronic kidney disease: a consensus statement from the International Society of Renal Nutrition and Metabolism (ISRNM).慢性肾脏病中蛋白质-能量消耗综合征的病因:国际肾脏营养与代谢学会(ISRNM)的共识声明。
J Ren Nutr. 2013 Mar;23(2):77-90. doi: 10.1053/j.jrn.2013.01.001.
9
Cachexia and protein-energy wasting in children with chronic kidney disease.儿童慢性肾脏病的恶病质和蛋白质能量消耗。
Pediatr Nephrol. 2012 Feb;27(2):173-81. doi: 10.1007/s00467-011-1765-5. Epub 2011 Feb 6.
10
Transcription factor NRF2 as potential therapeutic target for preventing muscle wasting in aging chronic kidney disease patients.转录因子 NRF2 作为预防老年慢性肾脏病患者肌肉减少症的潜在治疗靶点。
J Nephrol. 2022 Dec;35(9):2215-2225. doi: 10.1007/s40620-022-01484-w. Epub 2022 Nov 2.

引用本文的文献

1
Quality of life in older immigrant adults on hemodialysis.老年移民血液透析患者的生活质量
PLoS One. 2025 Sep 5;20(9):e0322426. doi: 10.1371/journal.pone.0322426. eCollection 2025.
2
Targeting Sarcopenia in CKD: The Emerging Role of GLP-1 Receptor Agonists.靶向慢性肾脏病中的肌肉减少症:胰高血糖素样肽-1受体激动剂的新作用
Int J Mol Sci. 2025 Aug 21;26(16):8096. doi: 10.3390/ijms26168096.
3
Is it true that lower PTH control is associated with lower levels of inflammatory cytokines in patients with chronic kidney disease?在慢性肾病患者中,较低的甲状旁腺激素(PTH)控制水平是否与较低水平的炎性细胞因子相关?

本文引用的文献

1
Low cholesterol in dialysis patients--causal factor for mortality or an effect of confounding?透析患者胆固醇水平低——是死亡的原因还是混杂因素的影响?
Nephrol Dial Transplant. 2011 Oct;26(10):3325-31. doi: 10.1093/ndt/gfr008. Epub 2011 Feb 28.
2
Low serum testosterone is associated with increased mortality in men with stage 3 or greater nephropathy.血清睾酮水平低与 3 期或更严重肾病患者的死亡率增加有关。
Am J Nephrol. 2011;33(3):209-17. doi: 10.1159/000324562. Epub 2011 Feb 18.
3
Soluble TWEAK and PTX3 in nondialysis CKD patients: impact on endothelial dysfunction and cardiovascular outcomes.
Ann Med. 2025 Dec;57(1):2541080. doi: 10.1080/07853890.2025.2541080. Epub 2025 Aug 9.
4
Comprehensive Insights into Sarcopenia in Dialysis Patients: Mechanisms, Assessment, and Therapeutic Approaches.透析患者肌肉减少症的综合见解:机制、评估和治疗方法
Medicina (Kaunas). 2025 Mar 4;61(3):449. doi: 10.3390/medicina61030449.
5
Chrononutrition in Chronic Kidney Disease.慢性肾脏病中的时间营养学
Nutrients. 2025 Jan 22;17(3):389. doi: 10.3390/nu17030389.
6
A Comparative Analysis of the SARC-F Questionnaire and the Malnutrition-Inflammation Score for Sarcopenia Risk Assessment and Negative Outcome Probability in Chronic Hemodialysis Patients.用于慢性血液透析患者肌肉减少症风险评估及不良结局概率的SARC-F问卷与营养不良-炎症评分的比较分析
J Clin Med. 2024 Sep 19;13(18):5554. doi: 10.3390/jcm13185554.
7
Association of Handgrip Strength and Nutritional Status in Non-Dialysis-Dependent Chronic Kidney Disease Patients: Results from the KNOW-CKD Study.非透析依赖型慢性肾脏病患者握力与营养状况的相关性:来自 KNOW-CKD 研究的结果。
Nutrients. 2024 Jul 26;16(15):2442. doi: 10.3390/nu16152442.
8
Narrative Review: Clinical Implications and Assessment of Frailty in Patients With Advanced CKD.叙述性综述:晚期慢性肾脏病患者衰弱的临床意义及评估
Kidney Int Rep. 2023 Dec 30;9(4):791-806. doi: 10.1016/j.ekir.2023.12.022. eCollection 2024 Apr.
9
Development and validation of a model for predicting the risk of cardiovascular events in maintenance hemodialysis patients.开发和验证一种用于预测维持性血液透析患者心血管事件风险的模型。
Sci Rep. 2024 Mar 21;14(1):6760. doi: 10.1038/s41598-024-55161-y.
10
Mapping the global research landscape on malnutrition for patients with chronic kidney disease: a visualization analysis.绘制慢性肾脏病患者营养不良相关全球研究图谱:可视化分析。
J Health Popul Nutr. 2023 Sep 23;42(1):101. doi: 10.1186/s41043-023-00445-8.
非透析慢性肾脏病患者可溶性 TWEAK 和 PTX3:对血管内皮功能障碍和心血管结局的影响。
Clin J Am Soc Nephrol. 2011 Apr;6(4):785-92. doi: 10.2215/CJN.09231010. Epub 2011 Feb 17.
4
Apoptosis and myostatin mRNA are upregulated in the skeletal muscle of patients with chronic kidney disease.在慢性肾脏病患者的骨骼肌中,细胞凋亡和肌肉生长抑制素 mRNA 上调。
Kidney Int. 2011 Apr;79(7):773-82. doi: 10.1038/ki.2010.494. Epub 2011 Jan 12.
5
Hemodialysis.血液透析
N Engl J Med. 2010 Nov 4;363(19):1833-45. doi: 10.1056/NEJMra0902710.
6
Rate of kidney function decline associates with mortality.肾功能下降的速度与死亡率相关。
J Am Soc Nephrol. 2010 Nov;21(11):1961-9. doi: 10.1681/ASN.2009121210. Epub 2010 Oct 14.
7
Malnutrition-inflammation modifies the relationship of cholesterol with cardiovascular disease.营养不良-炎症改变了胆固醇与心血管疾病的关系。
J Am Soc Nephrol. 2010 Dec;21(12):2131-42. doi: 10.1681/ASN.2009121285. Epub 2010 Sep 23.
8
Effect of circulating soluble receptor for advanced glycation end products (sRAGE) and the proinflammatory RAGE ligand (EN-RAGE, S100A12) on mortality in hemodialysis patients.可溶性晚期糖基化终产物受体(sRAGE)和促炎型 RAGE 配体(EN-RAGE,S100A12)对血液透析患者死亡率的影响。
Clin J Am Soc Nephrol. 2010 Dec;5(12):2213-9. doi: 10.2215/CJN.03360410. Epub 2010 Sep 16.
9
Asymmetric dimethylarginine (ADMA) induces chronic kidney disease through a mechanism involving collagen and TGF-β1 synthesis.非对称性二甲基精氨酸(ADMA)通过涉及胶原和 TGF-β1 合成的机制诱导慢性肾脏病。
J Pathol. 2011 Jan;223(1):37-45. doi: 10.1002/path.2769. Epub 2010 Sep 15.
10
Survival predictability of lean and fat mass in men and women undergoing maintenance hemodialysis.男性和女性维持性血液透析患者瘦体质量和脂肪质量的生存预测能力。
Am J Clin Nutr. 2010 Nov;92(5):1060-70. doi: 10.3945/ajcn.2010.29188. Epub 2010 Sep 15.